Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Myelodysplastic Syndromes 29Leukemia, Myeloid, Acute 28Lymphoma, Non-Hodgkin 26Leukemia, Lymphocytic, Chronic, B-Cell 23Lymphoma 22Hodgkin Disease 22Leukemia 18Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17Multiple Myeloma 14Hematologic Neoplasms 14Primary Myelofibrosis 11Myeloproliferative Disorders 11Lymphoma, Mantle-Cell 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Follicular 9Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myelomonocytic, Juvenile 8Leukemia, Myelomonocytic, Chronic 7Graft vs Host Disease 7Lymphoma, Large-Cell, Immunoblastic 6Burkitt Lymphoma 6Waldenstrom Macroglobulinemia 5Lymphoma, T-Cell, Cutaneous 5Leukemia, Myeloid, Accelerated Phase 5Congenital Abnormalities 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell 4Lymphoma, Extranodal NK-T-Cell 4Leukemia, Neutrophilic, Chronic 4

Interventions

thymoglobulin 1fludarabine 1Rituximab 1Melphalan 1Levetiracetam 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chromosome Aberrations × thymoglobulin × Lymphoid × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡